<乌鸦传媒>Milestone Reached for SGLT2 Inhibitor Aimed at Heart Attack Population Good signals in people with large acute MIs at risk of developing heart failure Aug 30, 2022
<乌鸦传媒>Transradial Access for Heart Procedures Saves Lives in Most Definitive Study Yet Approach beats coronary access through the thigh Aug 29, 2022
<乌鸦传媒>Finally, A Foundational Heart Failure Drug That Works Across the Spectrum of EF SGLT2 inhibitor shines in landmark DELIVER trial Aug 27, 2022
<乌鸦传媒>ADVOR Backs Add-On Acetazolamide for Cutting Congestion in Decompensated HF Exclusion of patients on SGLT2 inhibitors was a major trial limitation, expert says Aug 27, 2022
<乌鸦传媒>Mass Cardiovascular Testing May Add Years for Some Men Mixed results after the DANCAVAS program from Denmark Aug 27, 2022
<乌鸦传媒>No Detrimental Impact on Cognition With Entresto for Heart Failure Cost may be reason for underutilization, rather than concerns about cognition, expert noted Aug 26, 2022
<乌鸦传媒>No Worsening Cardiac Dysfunction in Long COVID Other harms likely contribute to dyspnea, HF after COVID-19 hospitalization Aug 05, 2022
<乌鸦传媒>Heart Disease Will Surge Over the Coming Decades Worsening racial disparities are also projected Aug 01, 2022
<乌鸦传媒>Fluid Therapy Showdown in Cardiac Surgery Disfavors Albumin Major adverse events not reduced, and some complications increased Jul 19, 2022
<乌鸦传媒>Bye-Bye, 'Life's Simple 7': AHA Redefines Cardiovascular Health by Adding Sleep New metrics and scoring algorithm for heart health in children and adults Jun 29, 2022
<乌鸦传媒>Which Advanced HF Patients Are Entresto-Intolerant in the Real World? 1 in 6 dropped out from the LIFE trial because of side effects Jun 27, 2022
<乌鸦传媒>Heart Failure Drugs Can Be Unaffordable on Medicare, Study Finds Older adults are subject to cost-sharing and other medication coverage restrictions Jun 21, 2022
<乌鸦传媒>TAVR Pacemaker Rate Dips to Single Digits Nationwide, but Outlier Hospitals Remain Do worst-performing sites need more education about best practices? Jun 12, 2022
<乌鸦传媒>Fate of Transcatheter Tricuspid Devices: Will it Be Repair or Replacement? Many unanswered questions remain regarding devices for tricuspid regurgitation Jun 11, 2022
<乌鸦传媒>TAVR Devices Keep Changing -- Is This Really Helping Patients? Clinical outcomes are headed in the right direction, but better research is needed Jun 10, 2022
<乌鸦传媒>Good News for Heart Failure Patients Getting COVID Booster Shots Group saw lower risks for hospitalization, ICU admission, death versus the unvaccinated Jun 09, 2022
<乌鸦传媒>TAVR for Aortic Regurgitation Off to a Good Start in the Real World Yet some growing pains remain for the Jenavalve Trilogy May 21, 2022
<乌鸦传媒>No-Implant Shunt Eases HF Symptoms in Early Data Quality of life consistently improved across first-in-man studies May 20, 2022
<乌鸦传媒>TAVR Stays Its Course as 10-Year Durability Data Trickle In Glimpse of longer-term valve degeneration in early TAVR patients May 19, 2022
<乌鸦传媒>Even With CKD, Patiromer Helped Heart Failure Patients Keep Hyperkalemia at Bay Promising findings from prespecified renal analysis of the DIAMOND trial Apr 09, 2022
<乌鸦传媒>Systemic Corticosteroids in Acute HF: Worth Another Look? Some see a potential treatment for patients with more inflammation Apr 08, 2022
<乌鸦传媒>Patiromer Limits Impact of RAAS Inhibitor-Related Hyperkalemia in HF Patients better able to achieve target dose of mineralocorticoids and angiotensin inhibitors Apr 04, 2022
<乌鸦传媒>EHR Pop-Ups Spur Better GDMT Implementation in Heart Failure Alert-based intervention in PROMPT-HF trial said to be low-cost, scalable Apr 03, 2022
<乌鸦传媒>Low-Salt Diet Helpful for HF Symptoms, but Not Necessarily for Clinical Events Sodium restriction still holds its ground in SODIUM-HF trial Apr 02, 2022
<乌鸦传媒>From 'Pre-HF' to 'HFimpEF': Guidelines Redefine Heart Failure Stages, Classes Update also adds SGLT2 inhibitor as a pillar of therapy Apr 01, 2022
<乌鸦传媒>In HFpEF, Do MRA Users Get as Much Benefit From an SGLT2 Inhibitor? EMPEROR-Preserved trial weighs in Mar 21, 2022
<乌鸦传媒>ARB-Cancer Link May Come Down to Cumulative Exposure Does a new paper resolve the conflicting safety data on the popular antihypertensives? Mar 02, 2022
<乌鸦传媒>Salt in Fizzy Tablets Linked to Heart, Death Risk Warning signals seen for fast-acting acetaminophen and other drugs Feb 24, 2022
<乌鸦传媒>A Simple Way to Tell When Asymptomatic Aortic Stenosis Isn't So Benign Could regular NT-proBNP testing be of value to patients with non-severe AS? Feb 16, 2022
<乌鸦传媒>ACIP Embraces Spikevax Amid Serious Talk of Changing mRNA Dosing Interval Would longer time between doses do the trick to reduce myocarditis risk? Feb 04, 2022
<乌鸦传媒>Death During Sex: Not Just an Old Man Thing But sudden cardiac death remains rare even for sexually active people with heart conditions Jan 12, 2022
<乌鸦传媒>Hospitalized Acute HF Patients See Clinical Benefits With Empagliflozin EMPULSE results support early start for the SGLT2 inhibitor, but more data needed, expert says Nov 16, 2021
<乌鸦传媒>Peak VO2 Improved After Beta-Blocker Withdrawal in Some HFpEF Patients Beta-blockers may not benefit HFpEF patients with chronotropic incompetence Nov 15, 2021
<乌鸦传媒>Delaying Surgery Hurts Patients With Silent Aortic Stenosis Early aortic valve replacement wins in AVATAR trial Nov 13, 2021
<乌鸦传媒>More Good News for Empagliflozin in Patients With Heart Failure Slower renal function decline with SGLT-2 inhibitor in EMPEROR-Preserved trial Nov 06, 2021
<乌鸦传媒>Longstanding Vascular Closure Technique Triumphs Over Collagen Plug Manta versus ProGlide after transfemoral TAVR in CHOICE-CLOSURE Nov 06, 2021
<乌鸦传媒>TAVR Operators Divided on Need for Bicuspid RCT Odds of a study coming to fruition are low Nov 05, 2021
<乌鸦传媒>Too Many TAVR Centers Are Clustered Around Well-to-Do Communities More centers not the answer to geographic, socioeconomic disparities in access? Oct 22, 2021
<乌鸦传媒>Study: Kids Exposed to Harmful Plastics During Heart Surgery Are tubing and blood bags sources of trouble? Oct 09, 2021
<乌鸦传媒>Post-TAVR Pacemakers Not All Doom and Gloom A bit of reassurance from Swedish cohort study Oct 04, 2021
